stockrowTeva Pharmaceutical Industries Ltd.
TEVA Healthcare Drug Manufacturers Specialty & Generic
Teva Pharmaceutical Industries Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $17.3 billion, up 4.32% from fiscal 2024.
- Revenue
- −1.90%
- EPS
- −47.2%
- Free cash flow
- −30.3%
- Total debt
- −0.43%
Quarter to September 2026, against a year earlier
Follow TEVA
Alert me
Teva Pharmaceutical Industries Ltd. (TEVA) Book value per share
Teva Pharmaceutical Industries Ltd.'s book value per share at the end of fiscal 2025 was 6.9×, up 45.3% from 4.8× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 6.8×. Over the past ten years it has ranged from 4.8× (fiscal 2024) to 36.6× (fiscal 2016); the current reading is higher than 18% of that period. Teva Pharmaceutical Industries Ltd. ranks 22nd of 84 Drug Manufacturers Specialty & Generic companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 6.9× | 45.30% |
| FY2024 | 4.8× | (34.49%) |
| FY2023 | 7.3× | (6.25%) |
| FY2022 | 7.7× | (24.08%) |
| FY2021 | 10.2× | 1.01% |
| FY2020 | 10.1× | (26.84%) |
| FY2019 | 13.8× | (10.75%) |
| FY2018 | 15.5× | (16.16%) |
| FY2017 | 18.4× | (49.65%) |
| FY2016 | 36.6× | 4.68% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 6.8× | 2.84% |
| Jun 2026 | 6.7× | (6.50%) |
| Mar 2026 | 7.1× | 3.03% |
| Dec 2025 | 6.9× | 9.29% |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| UTHR United Therapeutics Corporation compare | 147× |
| NBIX Neurocrine Biosciences, Inc. compare | 38.2× |
| ELAN Elanco Animal Health Incorporated compare | 13.2× |
| ZTS Zoetis Inc. compare | 7.5× |
| TEVA Teva Pharmaceutical Industries Ltd. | 6.8× |
| RDY Dr. Reddy's Laboratories Ltd compare | 4.9× |
| TAK Takeda Pharmaceutical Co. compare | 0.0× |
| HLN Haleon PLC Sponsored ADR compare | 0.0× |
| VTRS Viatris Inc. compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on TEVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement